Zobrazeno 1 - 10
of 53
pro vyhledávání: '"G Decoster"'
Autor:
Cathy Eng, G. Decoster, H.-J. Schmoll, Al B. Benson, Annette K. Larsen, Alberto Sobrero, A. de Gramont, Charles S. Fuchs, Harry Bleiberg, Masashi Fujii, John Zalcberg, Jean-Yves Douillard, Dominique Sprumont, Roberto Labianca, Edith P. Mitchell, Ph. Rougier, Benoist Chibaudel
Publikováno v:
Annals of Oncology
Annals of oncology :official journal of the European Society for Medical Oncology / ESMO, 28 (5
Annals of oncology :official journal of the European Society for Medical Oncology / ESMO, 28 (5
Background: In respect of the principle of autonomy and the right of self-determination, obtaining an informed consent of potential participants before their inclusion in a study is a fundamental ethical obligation. The variations in national laws, r
Autor:
J-L Liénard, E Quinaux, E Fabre-Guillevin, P Piedbois, A Jouhaud, G Decoster, M Buyse, null on behalf of the European Association for Research in Oncolo
Publikováno v:
Clinical Trials
Clinical Trials, SAGE Publications, 2006, 3, pp.486--492. ⟨10.1177/1740774506070807⟩
Clinical Trials, 2006, 3, pp.486--492. ⟨10.1177/1740774506070807⟩
Clinical Trials, SAGE Publications, 2006, 3, pp.486--492. ⟨10.1177/1740774506070807⟩
Clinical Trials, 2006, 3, pp.486--492. ⟨10.1177/1740774506070807⟩
Purpose To provide empirical evidence on the impact of on-site initiation visits on the following outcomes: patient recruitment, quantity and quality of data submitted to the trial coordinating office, and patients' follow-up time. Patients and metho
Autor:
J. von Pawel, C. Ewen, D. Tomita, U. Gatzemeier, Peter Johnson, Bernard Lebeau, G. Decoster, John Green, V. Trillet-Lenoir, Alain Depierre, Christian Manegold
Publikováno v:
European Journal of Cancer. 29:319-324
The aim of this study was to determine the usefulness of recombinant human granulocyte colony stimulating factor (r-metHuG-CSF) following conventional chemotherapy for small cell lung cancer. 130 previously untreated patients were randomised to recei
Publikováno v:
Annals of Oncology. 1:175-181
This review analysis consists of the antitumor activity and toxic deaths reported in single agent Phase I clinical trials using cytotoxic compounds published from 1972 to 1987. A total of 6639 patients with a variety of solid tumors and hematological
Autor:
Peter Johnson, Bernard Lebeau, J. Matcham, U. Gatzemeier, C. Ewen, V. Trillet-Lenoir, John Green, G. Decoster, J. von Pawel, Alain Depierre, Christian Manegold
Publikováno v:
European Journal of Cancer. 31:2115-2116
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G Decoster, Franco Cavalli, W.W. ten Bokkel Huinink, M. van Glabbeke, Georgette Renard, U. Bruntsch, Marcel Rozencweig, P Dombernowsky, Herman Høst, Vivien H.C. Bramwell
Publikováno v:
Journal of Clinical Oncology. 2:275-281
Sixty-three evaluable patients with advanced breast cancer were randomly allocated to receive three-week intravenous courses of carminomycin (18 mg/m2) or 4'-epidoxorubicin (90 mg/m2). The former yielded one (3%) partial response for nine weeks among
Publikováno v:
The Journal of Antibiotics. 32:820-827
delta 3-7 alpha-Phenylacetamidodesacetoxycephalosporanic acid was prepared by ring expansion of 6-epi-benzylpenicillin-S-sulfoxide, using N,O-bis(trimethylsilyl)acetamide (BSA) as silylating and dehydrating agent and alpha-picoline/alpha-picoline hyd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European journal of cancerclinical oncology. 25(11)
Doxifluridine, a new fluoropyrimidine analog, was administered to 21 patients with advanced colorectal carcinoma. The starting dose was 1.0 g/m2 given over 24 h for 90 consecutive days as a continuous infusion. Due to severe skin reactions (hand-foot